India Glycols Ltd
NSE:INDIAGLYCO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
709.85
1 488.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
India Glycols Ltd
Cost of Revenue
India Glycols Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
India Glycols Ltd
NSE:INDIAGLYCO
|
Cost of Revenue
-₹71.6B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Supreme Industries Ltd
NSE:SUPREMEIND
|
Cost of Revenue
-₹72.9B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
|
Tata Chemicals Ltd
NSE:TATACHEM
|
Cost of Revenue
-₹53.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
5%
|
|
|
Deepak Nitrite Ltd
NSE:DEEPAKNTR
|
Cost of Revenue
-₹59.7B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Berger Paints India Ltd
NSE:BERGEPAINT
|
Cost of Revenue
-₹66.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
|
Solar Industries India Ltd
NSE:SOLARINDS
|
Cost of Revenue
-₹32.9B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-17%
|
|
India Glycols Ltd
Glance View
India Glycols Ltd. operates as a holding company, which engages in the manufacture of industrial chemicals such as green technology based bulk, specialty and performance chemicals and natural gums and industrial gases, ethyl alcohol (Potable) and nutraceuticals. The company is headquartered in Kolkata, West Bengal. The Company’s segments include Bio-based Glycols (MEG, DEG, TEG and Heavy Glycols), Glycol Ethers, Glycol Ether Acetates, Ethylene Oxide Derivatives (EODs), Power Alcohol (Bio Fuel), Industrial Gases, Natural Gum (Bio Polymers), Ethyl Alcohol (Potable Spirits) and Extra Neutral Alcohol (ENA)and Ennature Biopharma (Nutraceuticals). Its products are Glycols (Bio-Based Specialties and Performance Chemicals), Ethyl Alcohol (Potable Spirits), Plant-based APIs and Nutraceuticals, Natural Gums (Bio Polymers), and Derivatives and Industrial Gases.
See Also
What is India Glycols Ltd's Cost of Revenue?
Cost of Revenue
-71.6B
INR
Based on the financial report for Jun 30, 2024, India Glycols Ltd's Cost of Revenue amounts to -71.6B INR.
What is India Glycols Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-10%
Over the last year, the Cost of Revenue growth was -20%. The average annual Cost of Revenue growth rates for India Glycols Ltd have been -11% over the past three years , -10% over the past five years .
You don't have any saved screeners yet
